Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7684386rdf:typepubmed:Citationlld:pubmed
pubmed-article:7684386lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0006556lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0081938lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C1334087lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0292863lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C2611253lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0439836lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:7684386lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:7684386pubmed:issue4lld:pubmed
pubmed-article:7684386pubmed:dateCreated1993-6-21lld:pubmed
pubmed-article:7684386pubmed:abstractTextThe monoclonal antibody 33B6 was found to be specific for the beta 1 integrin subunit. Treatment of leukocytes with this antibody induced a vigorous homotypic aggregation that had similar physiologic conditions as aggregation induced by a monoclonal antibody specific for the alpha 4 subunit. Expression of a beta 1 subunit on the cell surface was not sufficient for mAb 33B6-mediated aggregation to occur, since cells of the K562 erythroleukemia line failed to respond even though they expressed the beta 1 subunit and the 33B6 epitope. However, after transfection with cDNA encoding the alpha 4 subunit, K562 cells acquired the ability to aggregate in response to mAb 33B6 binding. By contrast, mAb 33B6 blocked cell binding to the endothelial surface protein vascular cell adhesion molecule-1 and the extracellular matrix protein fibronectin. These results suggest that the beta 1 epitope defined by mAb 33B6 may play a novel role in regulating leukocyte adhesive interactions.lld:pubmed
pubmed-article:7684386pubmed:languageenglld:pubmed
pubmed-article:7684386pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:citationSubsetIMlld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7684386pubmed:statusMEDLINElld:pubmed
pubmed-article:7684386pubmed:monthAprlld:pubmed
pubmed-article:7684386pubmed:issn0730-2312lld:pubmed
pubmed-article:7684386pubmed:authorpubmed-author:RenzMMlld:pubmed
pubmed-article:7684386pubmed:authorpubmed-author:FongSSlld:pubmed
pubmed-article:7684386pubmed:authorpubmed-author:BednarczykJ...lld:pubmed
pubmed-article:7684386pubmed:authorpubmed-author:McIntyreB WBWlld:pubmed
pubmed-article:7684386pubmed:authorpubmed-author:SzaboM CMClld:pubmed
pubmed-article:7684386pubmed:authorpubmed-author:WygantJ NJNlld:pubmed
pubmed-article:7684386pubmed:authorpubmed-author:Molinari-Stor...lld:pubmed
pubmed-article:7684386pubmed:issnTypePrintlld:pubmed
pubmed-article:7684386pubmed:volume51lld:pubmed
pubmed-article:7684386pubmed:ownerNLMlld:pubmed
pubmed-article:7684386pubmed:authorsCompleteYlld:pubmed
pubmed-article:7684386pubmed:pagination465-78lld:pubmed
pubmed-article:7684386pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:meshHeadingpubmed-meshheading:7684386-...lld:pubmed
pubmed-article:7684386pubmed:year1993lld:pubmed
pubmed-article:7684386pubmed:articleTitleHomotypic leukocyte aggregation triggered by a monoclonal antibody specific for a novel epitope expressed by the integrin beta 1 subunit: conversion of nonresponsive cells by transfecting human integrin alpha 4 subunit cDNA.lld:pubmed
pubmed-article:7684386pubmed:affiliationDepartment of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030.lld:pubmed
pubmed-article:7684386pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7684386pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7684386lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7684386lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7684386lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7684386lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7684386lld:pubmed